HIGHLIGHTS
- who: Di Liang et al. from the Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, China, School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China have published the research: Pharmacological Effects and Clinical Prospects of Cepharanthine, in the Journal: Molecules 2022, 8933 of 15/Dec/2022
- what: Based on the above-listed several new dosage forms of cepharanthine, we have summarized their advantages and disadvantages as well as those that need attention during clinical development.
SUMMARY
The human coronavirus OC43 model was used to screen 1900 clinically . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.